Skip to main content

Urothelial Carcinoma, Invasive

  • Living reference work entry
  • First Online:
Encyclopedia of Pathology

Part of the book series: Encyclopedia of Pathology ((EP))

  • 24 Accesses

Synonyms

Conventional-type; Infiltrating urothelial carcinoma; Invasive urothelial carcinoma; Urothelial carcinoma; Usual type

Definition

Malignant neoplasm arising from urothelium that shows pronounced ability for divergent differentiation with invasion beyond the basement membrane.

Clinical Features

  • Incidence

    Urothelial carcinoma represents the seventh most common cancer, and, among these, about 30% present with invasive disease.

  • Age

    The median patient age is 65–70 years, with age distribution from pediatric (uncommon) to old age.

  • Sex

    It is most common in male patients, with a male-to-female ratio of 3–4:1.

  • Site

    The bladder represents the most common site of invasive urothelial carcinoma (90%) among the urinary tract organs. The involvement of upper urinary tract organs occurs in about 10% of the cases. The involvement of urethra is uncommon; it occurs mainly in old patients with previous urothelial carcinoma of the bladder or upper urinary tract organs (Fig. 1). Multifocal...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Alfred Witjes, J., Lebret, T., Compérat, E. M., et al. (Eds.). (2017). Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. European Urology, 71, 462–475.

    Google Scholar 

  • American Joint Committee on Cancer (AJCC) Staging Manual, Eight Edition (2017). Editors: Amin, MB, Edge S, Greene F, Byrd DR, Brookland RK et al. Springer Ed.

    Google Scholar 

  • Amin, M. B., Trpkov, K., Lopez-Beltran, A., et al. (2014). Best practices recommendations in the application of immunohistochemistry in the bladder lesions: Report from the International Society of Urologic Pathology consensus conference. The American Journal of Surgical Pathology, 38, e20–e34.

    Article  Google Scholar 

  • Babjuk, M., Burger, M., Compérat, E. M., et al. (2019). European Association of Urology guidelines on non-muscle-invasive bladder Cancer (TaT1 and carcinoma in situ) – 2019 update. European Urology, 76, 639–657.

    Article  CAS  Google Scholar 

  • Bertz, S., Denzinger, S., Otto, W., Wieland, W. F., Stoehr, R., Hofstaedter, F., & Hartmann, A. (2011). Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series. Histopathology, 59, 722–732.

    Article  Google Scholar 

  • Brimo, F., Wu, C., Zeizafoun, N., et al. (2013). Prognostic factors in T1 bladder urothelial carcinoma: The value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion. Human Pathology, 44, 95–102.

    Article  Google Scholar 

  • Choi, W., Porten, S., Kim, S., et al. (2014). Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell, 25, 152–165.

    Article  CAS  Google Scholar 

  • Hasui, Y., Osada, Y., Kitada, S., & Nishi, S. (1994). Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer. Urology, 43, 782–786.

    Article  CAS  Google Scholar 

  • Moch, H., Pa, H., Ulbright, T. M., & Reuter, V. E. (2016). World Health Organization (WHO) classification of tumours of the urinary system and male genital organs (Vol. 8, 4th ed.). IARC: Press.

    Google Scholar 

  • Paner, G. P., Ro, J. Y., Wojcik, E. M., et al. (2007). Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: Implications for pathologic staging of invasive urothelial carcinoma. The American Journal of Surgical Pathology, 31, 1420–1429.

    Article  Google Scholar 

  • Rouprêt, M., Babjuk, M., Compérat, E., et al. (2018). European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. European Urology, 73, 111–122.

    Article  Google Scholar 

  • Sylvester, R. J., van der Meijden, A. P., Oosterlinck, W., et al. (2006). Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. European Urology, 49, 466–477.

    Article  Google Scholar 

  • van Rhijn, B. W., van der Kwast, T. H., & Alkhateeb, S. S. (2012). A new and highly prognostic system to discern T1 bladder cancer substage. European Urology, 61, 378–384.

    Article  Google Scholar 

  • Younes, M., Sussman, J., & True, L. D. (1990). The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer, 66, 543–548.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Rosaria Raspollini .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Raspollini, M.R., Lopez-Beltran, A. (2020). Urothelial Carcinoma, Invasive. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_5563-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28845-1_5563-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28845-1

  • Online ISBN: 978-3-319-28845-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics